Without being experts and trusting the company here, in my opinion this is excellent.
If it was not worth doing, why continue with it to waste money with so many other projects running?
Many clinical trials do not get to phase 2a, let alone phase 2b
I'll leave this one to the experts
Ann: Admedus Releases Results of HSV-2 Phase IIa Study, page-8
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
$5.62 |
Change
-0.230(3.93%) |
Mkt cap ! $87.13M | |||
| Open | High | Low | Value | Volume |
| $5.86 | $5.86 | $5.55 | $70.40K | 12.48K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 737 | $5.62 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $6.10 | 500 | 1 |
View Market Depth
| Last trade - 16.10pm 08/07/2025 (20 minute delay) ? |
| AVR (ASX) Chart |